Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... Rates of local tumor progression, overall survival, local progression-free survival, and event-free survival were evaluated by using the Kaplan-Meier method. The 1-, 2-, 3-, and 4-year rates of ...
2009 NOV 17 ... and 8 developed extensive chronic GVHD. With median follow-up of 39.1 months, event free survival and overall survival were 60.4% and 67.5%, respectively, at 5 yr. Events included ...
2009 NOV 23 ... event, heart failure and target vessel revascularisation. The projected 7-year event-free survival probability was 62.1% for those undergoing CABG, 77.1% for those who had PCI and 68.6% ...
2009 NOV 23 ... concluded: "We were also not able to establish the influence of markers on event free survival and overall survival because all children survived independent of initial clinical ...
2009 NOV 23 ... weeks is standard treatment for advanced ovarian carcinoma. Attempts to improve patient survival by including other drugs have yielded disappointing results," scientists writing in the ...
2009 NOV 25 ... report, researchers in the United States conducted a study "To determine event free Survival (EFS) of children with Wilms tumor (WT) and metastatic liver disease at diagnosis ...
2009 NOV 23 ... were 89.8% in the nonsurgical group and 85.4% in the surgical group (P=0.48). The 5-year event-free survival estimates were 74.2% and 82.8% in the nonsurgical and surgical groups, respectively ...
2009 NOV 16 ... as 30% of all deaths. Stem cell therapy offers significant therapeutic promise, but poor survival following transplantation to ischemic tissue limits its efficacy," scientists in Seoul, ...
2009 NOV 23 ... the United States, "Intraperitoneal (IP) chemotherapy is associated with an improved survival at the expense of increased toxicity in optimally debulked ovarian cancer patients. We ...
2009 NOV 28 ... N. Nishio and colleagues, Nagoya University.The researchers concluded: "Event-free survival did not significantly differ between patients with and without ES regardless of the ...
2009 NOV 23 ... (CTCAE) version 3.0, overall response rate (RR), time to progression disease and overall survival time. Gemcitabine 1250 mg/m2 was determined as the dose for Step 2. Adverse events ...
2009 NOV 17 ... University. The researchers concluded: "The cumulative recurrence-free survival rate of patients with a TGR of 1.0 or less was significantly higher than that of ...
2009 NOV 23 ... "Eukaryotic cells require iron for survival and have developed regulatory mechanisms for maintaining appropriate intracellular iron ...
2009 NOV 16 ... "Enzymes and biochemical mechanisms essential to survival are under extreme selective pressure and are highly conserved through evolutionary time. ...
2009 NOV 16 ... data in British Journal of Cancer. "Oesophageal cancer incidence is increasing and survival rates remain extremely poor. Natural agents with potential for chemoprevention include ...
2009 NOV 16 ... point was objective response rate (ORR). Secondary end points included progression-free survival (PFS), overall survival (OS), 1-year survival rate, and safety. Of 47 patients receiving ...
2009 NOV 16 ... able to help in the event of sudden cardiac emergencies, which will ultimately increase survival from the nation's leading cause of death." Keywords: Heart Attack, ...
2009 NOV 16 ... demonstrated that one solution can serve national security interests and ensure economic survival at the national level and in the private sector equally well." Vanguard ...
